Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists
摘要:
A series of novel 5,5-diphenylimidazolones was synthesized and evaluated for activity against the human neuropeptide Y5 receptor. The 3-pyridyl analog 46 demonstrated an IC50 of 8.3 nM with a favorable pharmacokinetic profile in rats, but was ineffective in reducing food intake. (c) 2006 Elsevier Ltd. All rights reserved.
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists
摘要:
A series of novel 5,5-diphenylimidazolones was synthesized and evaluated for activity against the human neuropeptide Y5 receptor. The 3-pyridyl analog 46 demonstrated an IC50 of 8.3 nM with a favorable pharmacokinetic profile in rats, but was ineffective in reducing food intake. (c) 2006 Elsevier Ltd. All rights reserved.
IMIDAZOLONE ANORECTIC AGENTS: II. PHENYL DERIVATIVES
申请人:Bristol-Myers Squibb Company
公开号:EP1066279A1
公开(公告)日:2001-01-10
US6054590A
申请人:——
公开号:US6054590A
公开(公告)日:2000-04-25
[EN] IMIDAZOLONE ANORECTIC AGENTS: II. PHENYL DERIVATIVES<br/>[FR] AGENTS ANOREXIGENES A BASE D'IMIDAZOLONES: DERIVES PHENYLES II
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:WO1999048888A1
公开(公告)日:1999-09-30
(EN) A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of phenyl derivatives of imidazolone compounds of Formula (I). As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.(FR) On a effectué la synthèse d'une série d'antagonistes non peptidergiques de NPY contenant des dérivés phényles de composés d'imidazolone représentés par la formule (I). Ces composés et leurs analogues connus sont censés exercer une action anorexigène efficace, en tant qu'antagonistes du réflexe alimentaire induit par NPY, afin de favoriser la perte de poids et de traiter des troubles de la nutrition.
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists
作者:Kevin W. Gillman、Mendi A. Higgins、Graham S. Poindexter、Marc Browning、Wendy J. Clarke、Sharon Flowers、James E. Grace、John B. Hogan、Rachel T. McGovern、Lawrence G. Iben、Gail K. Mattson、Astrid Ortiz、Stefanie Rassnick、John W. Russell、Ildiko Antal-Zimanyi
DOI:10.1016/j.bmc.2006.04.042
日期:2006.8
A series of novel 5,5-diphenylimidazolones was synthesized and evaluated for activity against the human neuropeptide Y5 receptor. The 3-pyridyl analog 46 demonstrated an IC50 of 8.3 nM with a favorable pharmacokinetic profile in rats, but was ineffective in reducing food intake. (c) 2006 Elsevier Ltd. All rights reserved.